Related Experiment Video
Updated: Jul 13, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Blood naltrexone levels over time following naltrexone implant
H T T Ngo1, D E Arnold-Reed, R C Hansson
1School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, D Block, Nedlands, Western Australia 6009, Australia.
Aims:
Oral naltrexone is used in the management of both heroin and alcohol dependence. However, poor compliance has limited its clinical utility. The study's objective was to determine the period of therapeutic coverage (>or=2 ng/ml) provided by a 3.3 g naltrexone subcutaneous implant compared with existing data on 1.1 g and 2.2 g implants.
Methods:
We assessed free blood naltrexone levels following treatment with a 3.3 g naltrexone implant in heroin dependent patients (n=50) in Perth, Western Australia. Results were compared with previously collated data for patients treated with either a 1.1 g (n=10) or 2.2 g (n=24) implant.
Results:
Following 3.3 g naltrexone implant treatment, free blood naltrexone levels remained above 2 ng/ml for 145 days (95% CI 125-167). In comparison, 1.1 g or 2.2 g implant treatment resulted in 95 days (95% CI 69-121) and 136 days (95% CI 114-158) coverage, respectively.
Conclusions:
The 3.3 g implant provides longer therapeutic coverage than the 1.1 g implant but not significantly longer than the 2.2 g implant.
More Related Videos
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Regimen: Multiple Oral Dosage
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant III: Nursing Management
Oral Drug Delivery Systems: Continuous-Release Systems

